Successful treatment of metastatic bladder cancer by gemcitabine-cisplatin re-challenge after pembrolizumab.

Takayuki AraiNobuyoshi TakeuchiTomokazu SazukaHiroaki SatoYusuke ImamuraShinichi SakamotoAkira KomiyaTomohiko Ichikawa

Published in: IJU case reports (2021)

We report a successful case in which gemcitabine-cisplatin re-challenge after pembrolizumab therapy was effective in metastatic bladder cancer. Re-administration of chemotherapy after immune checkpoint inhibitors may be a broadly effective treatment option.

Keyphrases

locally advanced
squamous cell carcinoma
small cell lung cancer
advanced non small cell lung cancer
rectal cancer
stem cells
bone marrow
mesenchymal stem cells
smoking cessation
muscle invasive bladder cancer